- Home
- PDSB vs SOL Comparison
PDSB vs SOL Comparison
Compare PDSB & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDSB
- SOL
- Stock Information
- Founded
- PDSB 2005
- SOL 2005
- Country
- PDSB United States
- SOL United States
- Employees
- PDSB N/A
- SOL N/A
- Industry
- PDSB Biotechnology: Pharmaceutical Preparations
- SOL Semiconductors
- Sector
- PDSB Health Care
- SOL Technology
- Exchange
- PDSB Nasdaq
- SOL Nasdaq
- Market Cap
- PDSB 114.9M
- SOL 109.2M
- IPO Year
- PDSB N/A
- SOL 2008
- Fundamental
- Price
- PDSB $2.01
- SOL $1.91
- Analyst Decision
- PDSB Strong Buy
- SOL Buy
- Analyst Count
- PDSB 3
- SOL 3
- Target Price
- PDSB $15.00
- SOL $3.83
- AVG Volume (30 Days)
- PDSB 526.2K
- SOL 233.8K
- Earning Date
- PDSB 11-14-2024
- SOL 11-14-2024
- Dividend Yield
- PDSB N/A
- SOL N/A
- EPS Growth
- PDSB N/A
- SOL N/A
- EPS
- PDSB N/A
- SOL N/A
- Revenue
- PDSB N/A
- SOL $102,489,000.00
- Revenue This Year
- PDSB N/A
- SOL $44.70
- Revenue Next Year
- PDSB N/A
- SOL $20.53
- P/E Ratio
- PDSB N/A
- SOL N/A
- Revenue Growth
- PDSB N/A
- SOL 25.98
- 52 Week Low
- PDSB $1.53
- SOL $1.41
- 52 Week High
- PDSB $6.74
- SOL $3.00
- Technical
- Relative Strength Index (RSI)
- PDSB 19.40
- SOL 32.00
- Support Level
- PDSB $1.53
- SOL $2.00
- Resistance Level
- PDSB $3.41
- SOL $2.18
- Average True Range (ATR)
- PDSB 0.27
- SOL 0.16
- MACD
- PDSB -0.12
- SOL -0.06
- Stochastic Oscillator
- PDSB 24.62
- SOL 16.67
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.